Evidence map›Paper›PMID 41750627›Full record

ReviewAntioxidants (Basel, Switzerland)2026

Functional Benefits of Brewer's Spent Grain and the Challenge of Developing Food Ingredients for Human Health.

Carmen Soto-Maldonado, Alejandra Espinosa, José Luis Bucarey, Lida Fuentes

Abstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Carmen Soto-MaldonadoCentro Regional de Estudios en Alimentos Saludables (CREAS), Avenida Universidad 330, Placilla, Curauma, Valparaiso 2362696, Chile.ORCID 0000-0002-2465-9032
Alejandra EspinosaSchool of Medicine, Faculty of Medicine, Universidad de Valparaiso, San Felipe 2172972, Chile.
José Luis BucareySchool of Medicine, Faculty of Medicine, Universidad de Valparaiso, San Felipe 2172972, Chile.ORCID 0000-0003-4990-3385
Lida FuentesCentro Regional de Estudios en Alimentos Saludables (CREAS), Avenida Universidad 330, Placilla, Curauma, Valparaiso 2362696, Chile.ORCID 0000-0003-0605-2824

Funding

Agencia Nacional de Investigación y Desarrollo CTI2500006Agencia Nacional de Investigación y Desarrollo R23F0004
6 · The paper itself

Abstract

Recent developments have highlighted the importance of using by-products such as brewer's spent grain (BSG) as functional food ingredients. BSG is a source of polyphenols, antioxidants, dietary fiber, and protein, all of which are crucial for preventing metabolic syndrome and cardiovascular disease. This review focuses on bioactive compounds in BSG, such as ferulic and p-coumaric acids, which are distinguished for their antioxidant and anti-inflammatory properties. These compounds play a vital role in liver protection by boosting antioxidant enzyme activity and reducing inflammation and oxidative stress. Additionally, arabinoxylans (AX) in BSG enhance gut health by promoting the growth of beneficial microbiota. The review also identifies gaps in understanding how processing affects bioactive compound bioavailability in foods, emphasizing the need for innovative food technologies to enhance nutrient release and absorption, including the recent studies that show the role of gut microbiota in fermenting BSG components, leading to the release of beneficial compounds, such as ferulic and butyric, which positively influence health and metabolism. Despite these advancements, further research is essential to explore the interactions within the gut, liver effects, and the overall health benefits of BSG, aiming to optimize processing techniques to preserve its nutritional value and promote sustainable food innovation.

Indexed as

anti-inflammatory actionantioxidant actionarabinoxylansbeer by-productbioprocessingbrewer’s bagassediet fiberferulic acidp-coumaric acid

Identifiers

PMID41750627
PMCPMC12938687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.